Pasi Jänne
Director · Yale University
Pasi Jänne directs the Lowe Center for Thoracic Oncology at Dana-Farber and co-discovered EGFR mutations predicting lung cancer response to gefitinib.
About
Pasi Jänne directs the Lowe Center for Thoracic Oncology at Dana-Farber and co-discovered EGFR mutations predicting lung cancer response to gefitinib. At Yale grand rounds, Jänne traces, at research level, how drug-tolerant persister cells survive EGFR inhibition via BCL-XL and YAP signaling.
Taught with
Same subject, Medicine & Health
Connections
6Their places, courses, books and lectures.
